Zunarsh Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 10-12-2024
- Paid Up Capital ₹ 1.00 M
as on 10-12-2024
- Company Age 6 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -23.08%
(FY 2021)
- Profit -29.66%
(FY 2021)
- Ebitda -27.96%
(FY 2021)
- Net Worth 5.05%
(FY 2021)
- Total Assets 15.41%
(FY 2021)
About Zunarsh Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Hareesh Manglipelly, Prashanth Bijja, and Garikipati Anandbabu serve as directors at the Company.
- CIN/LLPIN
U74994TG2017PTC121460
- Company No.
121460
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Dec 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Zunarsh Lifesciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hareesh Manglipelly  | Director | 19-Jan-2021 | Current |
| Prashanth Bijja | Director | 06-Mar-2023 | Current |
| Garikipati Anandbabu | Additional Director | 11-Oct-2024 | Current |
Financial Performance of Zunarsh Lifesciences.
Zunarsh Lifesciences Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 23.08% decrease. The company also saw a substantial fall in profitability, with a 29.66% decrease in profit. The company's net worth moved up by a moderate rise of 5.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zunarsh Lifesciences?
In 2021, Zunarsh Lifesciences had a promoter holding of 45.00% and a public holding of 55.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Zunarsh Lifesciences?
Zunarsh Lifesciences has a workforce of 0 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zunarsh Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zunarsh Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
